Select Page

Latest News

June 30, 2022
Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order

June 16, 2022
Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

May 26, 2022
Rapid Dose Therapeutics Corp Announces Proposed Private Placement

May 25, 2022
Rapid Dose Therapeutics Closes First Tranche of Private Placement

May 12, 2022
Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom

April 26, 2022
Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

March 7, 2022
RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission — the value of needle-free vaccination, such as the QuickStrip™, will be discussed.

February 10, 2022
Rapid Dose Therapeutics Announces Management Change

January 5, 2022
Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

December 22, 2021
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant

1 2 3 4 5 6 7 8 9